IVC diameter in patients with chronic heart failure: relationships and prognostic significance

Pierpaolo Pellicori1, Valentina Carubelli, Jufen Zhang

  • 1Department of Academic Cardiology, Hull and East Yorkshire Medical Research and Teaching Centre, Castle Hill Hospital, Cottingham, Kingston upon Hull, United Kingdom. pierpaolo.pellicori@hey.nhs.uk

Insights

In chronic heart failure (HF) patients, a larger inferior vena cava (IVC) diameter indicates a higher risk of adverse outcomes, independent of other clinical factors. This finding aids in predicting prognosis for heart failure patients.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Medical Imaging

Background:

  • The inferior vena cava (IVC) diameter reflects right atrial pressure, potentially serving as an independent marker of heart failure (HF) severity.
  • Previous research has not fully explored the relationship between IVC diameter, clinical variables, and prognostic significance in HF patients.

Purpose of the Study:

  • To investigate the association between IVC diameter and clinical characteristics.
  • To determine the prognostic value of IVC diameter in patients with chronic heart failure (HF).

Main Methods:

  • A cohort of 693 outpatients with chronic HF was enrolled between 2008 and 2010.
  • HF was diagnosed based on symptoms, signs, and objective cardiac dysfunction (LVEF <45% or left atrial dilation with elevated NT-proBNP).
  • Patients were followed for a composite endpoint of cardiovascular death and HF hospitalization.

Main Results:

  • Patients in the highest tertile of IVC diameter were older, had lower BMI, higher prevalence of atrial fibrillation, and received more diuretics.
  • Increased IVC diameter correlated with higher left atrial volumes, pulmonary pressures, and NT-proBNP levels.
  • Multivariable analysis revealed that increasing IVC diameter, urea, and trans-tricuspid systolic gradient independently predicted poor outcomes, while LVEF and global longitudinal strain did not.

Conclusions:

  • Increasing IVC diameter is a significant independent predictor of adverse outcomes in patients with chronic heart failure.
  • This measurement provides valuable prognostic information, particularly in patients with or without reduced left ventricular ejection fraction (LVEF).
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...